{"id":"https://openalex.org/W26225820","doi":null,"title":"Finanzierung von Arzneimittelstudien durch pharmazeutische Unternehmen und die Folgen","display_name":"Finanzierung von Arzneimittelstudien durch pharmazeutische Unternehmen und die Folgen","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W26225820","mag":"26225820"},"language":"en","primary_location":{"id":"mag:26225820","doi":null,"is_oa":false,"landing_page_url":"https://www.akdae.de/Stellungnahmen/Weitere/20100429.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5006930847","display_name":"Gisela Schott","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gisela Schott","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011722882","display_name":"Henry Pachl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Henry Pachl","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018356512","display_name":"Ulrich Limbach","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ulrich Limbach","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043106486","display_name":"Ursula Gundert\u2010Remy","orcid":"https://orcid.org/0000-0002-4013-5079","observed_orcids":["https://orcid.org/0000-0002-4013-5079"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ursula Gundert\u2010Remy","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-4013-5079","affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Wolfgang Ludwig","orcid":"https://orcid.org/0000-0002-3256-3831","observed_orcids":["https://orcid.org/0000-0002-3256-3831"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wolfgang Ludwig","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3256-3831","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5009522199","display_name":"Klaus Lieb","orcid":"https://orcid.org/0000-0002-9609-4261","observed_orcids":["https://orcid.org/0000-0002-9609-4261"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Klaus Lieb","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9609-4261","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":1.1787,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":{"value":0.81456341,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T12816","display_name":"Global Public Health Policies and Epidemiology","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-industry-funding","display_name":"pharmaceutical industry funding","score":0.7590000033378601},{"id":"https://openalex.org/keywords/drug-trials","display_name":"drug trials","score":0.7369999885559082},{"id":"https://openalex.org/keywords/conflict-of-interest","display_name":"conflicts of interest","score":0.8230000138282776},{"id":"https://openalex.org/keywords/financial-conflicts-of-interest","display_name":"financial conflicts of interest","score":0.5889999866485596},{"id":"https://openalex.org/keywords/trial-results","display_name":"trial outcomes","score":0.34299999475479126},{"id":"https://openalex.org/keywords/study-protocol-design","display_name":"study protocol design","score":0.5509999990463257},{"id":"https://openalex.org/keywords/methodological-quality-of-trials","display_name":"methodological quality of trials","score":0.7850000262260437},{"id":"https://openalex.org/keywords/industry-influence-on-research","display_name":"industry influence on research","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6632867455482483},{"id":"https://openalex.org/C2779652045","wikidata":"https://www.wikidata.org/wiki/Q507443","display_name":"Pharmaceutical industry","level":2,"score":0.6437572240829468},{"id":"https://openalex.org/C2992672634","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Drug trial","level":3,"score":0.5182476043701172},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.49166446924209595},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.45964527130126953},{"id":"https://openalex.org/C134121241","wikidata":"https://www.wikidata.org/wiki/Q899301","display_name":"Yield (engineering)","level":2,"score":0.43231919407844543},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.41750526428222656},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39089471101760864},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.37079036235809326},{"id":"https://openalex.org/C17744445","wikidata":"https://www.wikidata.org/wiki/Q36442","display_name":"Political science","level":0,"score":0.31133854389190674},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.21810224652290344},{"id":"https://openalex.org/C199539241","wikidata":"https://www.wikidata.org/wiki/Q7748","display_name":"Law","level":1,"score":0.06960546970367432},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.06941816210746765},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.06609693169593811},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.0},{"id":"https://openalex.org/C191897082","wikidata":"https://www.wikidata.org/wiki/Q11467","display_name":"Metallurgy","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:26225820","doi":null,"is_oa":false,"landing_page_url":"https://www.akdae.de/Stellungnahmen/Weitere/20100429.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[{"id":"https://openalex.org/G7469729476","display_name":"NANOparticle-based FLEXIble TOUCH surfaces","funder_award_id":"ANR-12-NANO-0015","funder_id":"https://openalex.org/F4320320883","funder_display_name":"Agence Nationale de la Recherche"}],"funders":[{"id":"https://openalex.org/F4320320883","display_name":"Agence Nationale de la Recherche","ror":"https://ror.org/00rbzpz17"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":54,"referenced_works":["https://openalex.org/W89601973","https://openalex.org/W1523498755","https://openalex.org/W1828984482","https://openalex.org/W1855359123","https://openalex.org/W1970259524","https://openalex.org/W1980599286","https://openalex.org/W1986215651","https://openalex.org/W1999175005","https://openalex.org/W2016300030","https://openalex.org/W2022364336","https://openalex.org/W2022866457","https://openalex.org/W2023482608","https://openalex.org/W2024438548","https://openalex.org/W2024719656","https://openalex.org/W2030218251","https://openalex.org/W2031244707","https://openalex.org/W2037624670","https://openalex.org/W2041268878","https://openalex.org/W2043355327","https://openalex.org/W2043962455","https://openalex.org/W2052494740","https://openalex.org/W2055288923","https://openalex.org/W2056916538","https://openalex.org/W2099086046","https://openalex.org/W2103278721","https://openalex.org/W2103637454","https://openalex.org/W2104389711","https://openalex.org/W2107312434","https://openalex.org/W2108010518","https://openalex.org/W2115331273","https://openalex.org/W2115881392","https://openalex.org/W2119870271","https://openalex.org/W2121002642","https://openalex.org/W2121671594","https://openalex.org/W2121829083","https://openalex.org/W2127645603","https://openalex.org/W2130443012","https://openalex.org/W2135049224","https://openalex.org/W2136284733","https://openalex.org/W2138309554","https://openalex.org/W2139294235","https://openalex.org/W2140232133","https://openalex.org/W2142947341","https://openalex.org/W2143962486","https://openalex.org/W2149843684","https://openalex.org/W2152340675","https://openalex.org/W2153292291","https://openalex.org/W2158221019","https://openalex.org/W2162992086","https://openalex.org/W2167535272","https://openalex.org/W2168787182","https://openalex.org/W2169698098","https://openalex.org/W2183197310","https://openalex.org/W4246599781"],"related_works":["https://openalex.org/W1524740654","https://openalex.org/W2136284733","https://openalex.org/W4255633103","https://openalex.org/W7097832061","https://openalex.org/W2031244707","https://openalex.org/W2032294664","https://openalex.org/W6964739969","https://openalex.org/W2943510301","https://openalex.org/W2107312434","https://openalex.org/W2166116545"],"abstract_inverted_index":{"SUMMARY":[0],"The":[1,185,216],"Financing":[2],"of":[3,18,30,38,80,83,115,142,161,219,234],"Drug":[4,31],"Trials":[5],"by":[6,47,113,122,151,222,246,258],"Pharmaceutical":[7],"Companies":[8],"and":[9,28,111,140,267],"Its":[10],"Consequences:":[11],"Part":[12],"1.":[13],"A":[14],"Qualitative,":[15],"Systematic":[16],"Review":[17],"the":[19,25,81,116,170],"Literature":[20],"on":[21,24,87,97],"Possible":[22],"Influences":[23],"Findings,":[26],"Protocols,":[27],"Quality":[29],"TrialsBackground:":[32],"In":[33],"recent":[34],"years,":[35],"a":[36,93,158,209,251],"number":[37],"studies":[39,86],"have":[40,65],"shown":[41],"that":[42,148,202,211,233,243],"clinical":[43],"drug":[44,70,146,171,241],"trials":[45,60,71,147,178,220,235,242,266,268],"financed":[46,150,177,196,221,245,269],"pharmaceutical":[48,63,203,223],"companies":[49,64,204,224,248],"yield":[50,166],"fa-vorable":[51],"results":[52,168,186],"for":[53,135,169],"company":[54],"products":[55],"more":[56,173,191],"often":[57,192],"than":[58,175,193,232],"independent":[59],"do.":[61],"Moreover,":[62],"been":[66],"found":[67,125,164,227],"to":[68,104,165,214,228],"influence":[69],"in":[72,126,137,194,208,237,261,270],"various":[73],"ways.":[74],"This":[75,254],"paper":[76],"provides":[77],"an":[78],"over-view":[79],"findings":[82],"current,":[84],"systematic":[85,94],"this":[88,98,143],"topic.Methods:":[89],"Publications":[90],"retrieved":[91],"from":[92,100],"Medline":[95],"search":[96],"topic":[99],"1":[101,139],"November":[102],"2002":[103],"16":[105],"December":[106],"2009":[107],"were":[108,120,133,149,163,187],"independently":[109,176,195],"evaluated":[110],"selected":[112],"two":[114],"authors.":[117],"These":[118],"publications":[119,132],"supplemented":[121],"further":[123],"ones":[124],"their":[127],"refe-rences":[128],"sections.":[129],"Results:":[130],"57":[131],"included":[134],"evaluation":[136],"Parts":[138],"2":[141],"article.":[144],"Published":[145,240],"phar-maceutical":[152],"companies,":[153],"or":[154],"whose":[155,179],"authors":[156,180],"declared":[157],"financial":[159],"con-flict":[160],"interest,":[162],"favorable":[167,213],"manufacturer":[172],"frequently":[174],"had":[181],"no":[182],"such":[183,265],"conflicts.":[184],"also":[188],"inter-preted":[189],"favorably":[190],"trials.":[197],"Furthermore,":[198],"there":[199],"was":[200,212,225],"evidence":[201],"influenced":[205],"study":[206],"protocols":[207],"way":[210],"themsel-ves.":[215],"methodological":[217,262],"quality":[218,263],"not":[226],"be":[229,256],"any":[230,259],"worse":[231],"finan-ced":[236],"other":[238,271],"ways.Conclusion:":[239],"are":[244],"pharmaceuti-cal":[247],"may":[249],"present":[250],"distorted":[252],"picture.":[253],"cannot":[255],"ex-plained":[257],"difference":[260],"between":[264],"ways.Zitierweise:":[272],"Dtsch":[273],"Arztebl":[274],"Int":[275],"2010;":[276],"107(16):":[277],"279\u201385":[278],"DOI:":[279],"10.3238/arztebl.2010.0279":[280]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2016-06-24T00:00:00"}